Table 1.
Sample characteristics.
| EUGEI | GROUP (replication)a | |||
|---|---|---|---|---|
| Control | Sibling | Patients | Patients | |
| Age in mean (SD) | 33.9 (10.4) | 34.1 (9.4) | 33.7 (8.6) | 27.6 (8.0) |
| Sex | ||||
| Male | 771 (50.62%) | 586 (45.82%) | 840 (66.67%) | 852 (76.14%) |
| Female | 752 (49.38%) | 693 (54.18%) | 420 (33.33%) | 267 (23.86%) |
| Education | ||||
| 1 | 28 (1.89%) | 35 (2.81%) | 57 (4.72%) | 151 (13.90%) |
| 2 | 303 (20.45%) | 213 (17.11%) | 278 (23.03%) | 341 (31.40%) |
| 3 | 260 (17.54%) | 227 (18.23%) | 320 (26.51%) | 270 (24.86%) |
| 4 | 425 (28.68%) | 325 (26.10%) | 356 (29.49%) | 281 (25.87%) |
| 5 | 466 (31.44%) | 445 (35.74%) | 196 (16.24%) | 43 (3.96%) |
| ES-SCZ in mean (SD) | 2.7 (0.8) | 3.1 (1.0) | 3.8 (1.2) | 4.4 (1.4) |
| GAF symptom in mean (SD) | 87.6 (6.8) | 82.0 (12.6) | 51.0 (17.7) | 55.9 (16.0) |
| GAF disability in mean (SD) | 88.7 (6.0) | 84.4 (11.8) | 52.0 (17.9) | 54.5 (16.2) |
Abbreviations: EUGEI, the European Network of National Networks Studying Gene–Environment Interactions in Schizophrenia; ES-SCZ, exposome score for schizophrenia; GAF, Global Assessment of Functioning; GROUP, the Genetic Risk and Outcome of Psychosis.
a
The patient population of the GROUP served as the replication dataset.